Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details Physician Access to Pharmaceuticals |
One Touch Rx Inc.
|
Mr. Adrian Plesha | |||
| Details Promoting consumer benefits of authorized generic drugs |
Prasco, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
| Details Biodefense funding issues in the US House, US Senate and other agencies. |
AVI BIOPHARMA, INC.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
| Details General advocacy for the Ohio bioscience industry. |
BioOhio
Advocacy for the bioscience industry in Ohio, economic development |
Colby & Company | |||
| Details General advocacy for the Ohio bioscience industry. |
BioOhio
Advocacy for the bioscience industry in Ohio, economic development |
Colby & Company | |||
| Details HR 3200 the Americas Affordable Health Choices Act of 2009 and the Federal 340B Program that provides prescription drug discount for qualified community health centers and medical institutions |
SUNRx
Pharmaceutical benefit manager |
THE LIVINGSTON GROUP, L.L.C. | |||
| Details Implementation of the Patient Protection and Affordable Care Act; Issues related to government efforts to roll out the COVID vaccination system. Discussions surrounding pending tax related provisio... |
PhRMA (on behalf of We Work for Health)
|
Capitol Legislative Strategies LLC | |||
| Details H.R. 3590 - Patient Protection and Affordability Act relating to PBM transparency H.R. 616 & S. 511 - Relating to pharmacy exemption from Medicare Accreditation requirements H.R. 3590 - Patient Pro... |
National Community Pharmacists Association
|
Brown Rudnick LLP | |||
| Details patent issue; H.R.5486, Small Business Jobs Tax Relief Act of 2010 |
The Medicines Company
manufacture and marketing of pharmaceutical drugs |
Gephardt Group Government Affairs | |||
| Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying | |||
| Details matters pertaining to pharmacy matters |
Lilly USA
|
Roetzel & Andress, LPA | |||
| Details Reverse payments settlements by generic drug companies and pharmaceutical drug companies |
Nephron Pharmaceutical Corporation
|
FOLEY & LARDNER LLP | |||
| Details Issues relative to generic pharmaceuticals and generic biologics; FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related ... |
Generic Pharmaceutical Association
|
The Russell Group, Inc. (formerly Russell & Barron, Inc.) | |||
| Details S. 515, patent reform issues relating to prior use rights. |
Daiichi Sankyo, Inc.
|
K&L GATES LLP | |||
| Details No lobbying activity in 2020. Client was terminated effective December 31, 2019. |
Emergent BioSolutions, Inc.
|
DAVIS & HARMAN LLP | |||
| Details Long-term Care Pharmacy |
Senior Care Pharmacy Alliance
|
Tiboni Associates, Inc. | |||
| Details vaccine related issues |
Sanofi Pasteur
|
Ogilvy Government Relations | |||
| Details Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program Issues H.R. 3590 Patient Protection and Affordable Care Act- H.R. 616 Pharmacists Exemption to CMS DME R... |
Diabetes Access to Care Coalition (DACC)
|
WINNING STRATEGIES WASHINGTON | |||
| Details Regulations governing the availability of the full range of the client's products in certain Latin American Markets. |
Schering Corporation
|
Vision Americas | |||
| Details Issues relating to the biotechnology industry. Issues relating to the biotechnology industry. Worked on HR 1548, the follow-on to To amend the Public Health Service Act; and HR 3962 the bill to pr... |
Biotechnology Industry Organization
|
HOLLAND & KNIGHT LLP | |||
| Details S. 214, the Preserve Access to Affordable Generics Act |
TEVA Pharmaceuticals USA Inc.
|
Kevin McGuiness PLLC | |||
| Details - Docket ID: FDA-2007-N-0363: Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Product - H.R. 1625 (P.L. 115-14): Consolidated Appropriations Act, 2018: Div... |
Pharmaceutical Printed Literature Association
|
EVERGREEN ASSOCIATES, LTD. | |||
| Details EDA, EPA regulations with colloid minerals |
Purest Colloids
|
Management & Government Resources | |||
| Details HR 3200 the Americas Affordable Health Choices Act of 2009 and the Federal 340B Program that provides prescription drug discount for qualified community health centers and medical institutions |
SUNRx
Pharmaceutical benefit manager |
THE LIVINGSTON GROUP, L.L.C. | |||
| Details Health Care Reform Immigration Inclusion in Health Reform Health Disparities Small Business Health Care |
Washington Community Action Network
|
Mr. William Daley | |||
| Details Advocate to the Federal Government for Novogix to develop cost management programs for higher-cost pharmaceuticals. |
Novologix
|
THE LIVINGSTON GROUP, L.L.C. | |||
| Details Rural hospital policies Rural Hospital Support Act (S.1110) Graduate Medical Education (GME) funding (Resident Physician Shortage Reduction Act (S.1302, H.R.2389) Metropolitan Anchor Hospitals Tele... |
UNIVERSITY OF PITTSBURGH MEDICAL CENTER
|
in-house lobbying | |||
| Details Biogenerics S. 369, Patent settlement |
TEVA Pharmaceuticals USA
|
WINSTON & STRAWN LLP | |||
| Details Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy American Health Choices Act of 2009 H.R. 3200 American Health Choices Act of 2009 Tri C... |
Winning Strategies Washington, LLC
|
PODESTA GROUP, INC. | |||
| Details Medicare Advantage CMMI |
Healthcare Leadership Council
|
Allison + Partners |